Recommendations on Qualification and Validation
The PIC/S recommendations on qualification and validation, written as guidance and a training resource for GMP inspectors and industry alike — which makes it, like PI 041, an unusually direct view of what inspectors expect. It covers the validation master plan, prequalification and the IQ/OQ/PQ stages for facilities, utilities, equipment and systems, requalification, process validation, and cleaning validation. PI 006-4 enters into force 1 October 2026.
Always verify against the current published text before relying on it for a submission or inspection.
Scope & applicability
The principles apply equally to active pharmaceutical ingredients, intermediates and finished dosage forms. Deliberately narrower than it looks: PI 006-4 does not cover computerised-system validation, which sits in Annex 11, does not treat analytical method validation in depth, and does not repeat validation topics already covered by other PIC/S documents such as PI 007 on aseptic processes. It supplements Annex 15 rather than restating it — the topics are the areas PIC/S inspectorates identified as needing more guidance than Annex 15 gives.
Quick reference · PI 006 version history
Every version of the PIC/S qualification and validation recommendations, and the date each entered into force. PI 006-4 supersedes PI 006-3 on 1 October 2026.
| Version | Entered into force |
|---|---|
| Adoption by PIC/S Committee | 10–11 December 1998 |
| PR 1/99-1 | 1 March 1999 |
| PI 006-1 | 1 September 2001 |
| PI 006-2 | 1 July 2004 |
| PI 006-3 | 25 September 2007 |
| PI 006-4 | 1 October 2026 |
PI 006-3 stood for nineteen years. If your validation master plan cites it by number, that citation goes stale on 1 October 2026 — and PI 006-4 also renames the document, so a title-based reference breaks too.
Source: PIC/S PI 006-4 §1 Document History. Verify against the current text before relying on it for a submission.
Key requirements
- Maintain a validation master plan with a defined principle, purpose, scope, format and content
- Run prequalification stages before the qualification stages proper, then IQ, OQ and PQ for facilities, supporting utilities, equipment and systems
- Define and justify requalification, rather than treating qualification as a one-time event
- Apply quality risk management principles throughout qualification and validation
- Validate cleaning processes, including visual inspection, sampling, detergents, analytical methods, limit-setting, and maintaining the validated state
- Govern change through the pharmaceutical quality system, which PI 006-4 treats as equivalent to change management
Implementation tips
- Diary the 1 October 2026 changeover: any VMP, SOP or protocol citing PI 006-3 by number or by its old title needs updating
- Read §2.2 before assuming coverage — computerised systems and analytical methods are explicitly out of scope and live in Annex 11 and elsewhere
- Use §4 to structure prequalification and the IQ/OQ/PQ ladder for utilities and equipment, not just for process equipment
- Pair it with Annex 15: PI 006-4 is supplementary guidance on the areas inspectors found Annex 15 too thin on
Revision notes
PI 006-4 enters into force 1 October 2026, superseding PI 006-3 of 25 September 2007 — a nineteen-year gap. It also renames the document: PI 006-3 was titled “Recommendations on validation master plan, installation and operational qualification, non-sterile process validation, cleaning validation”, and PI 006-4 is simply “Recommendations on Qualification and Validation”, reflecting the 2015 revision of Annex 15. PIC/S announced the revision on 30 July 2026; the working group was chaired successively by Norman Gray (MHRA) and then jointly by Kevin O’Donnell (HPRA) and Rebecca Dowd (US FDA). Separately, EMA and PIC/S have agreed a concept paper on revising Annex 15 itself (EMA/INS/GMP/163466/2026, 19 January 2026), so the underlying annex is also in motion.
Where this control fails
live FDA enforcementLive FDA recalls SPEQ maps to this standard’s topics — a SPEQ interpretation, not an FDA classification.
PIC/S PI 006-4: frequently asked questions
Quick answers to common questions about PIC/S PI 006-4.
What is PIC/S PI 006-4?
PIC/S PI 006-4 — Recommendations on Qualification and Validation — is a guidance issued by the Pharmaceutical Inspection Co-operation Scheme. The PIC/S recommendations on qualification and validation, written as guidance and a training resource for GMP inspectors and industry alike — which makes it, like PI 041, an unusually direct view of what inspectors expect. It covers the validation master plan, prequalification and the IQ/OQ/PQ stages for facilities, utilities, equipment and systems, requalification, process validation, and cleaning validation. PI 006-4 enters into force 1 October 2026.
Who does PIC/S PI 006-4 apply to?
The principles apply equally to active pharmaceutical ingredients, intermediates and finished dosage forms. Deliberately narrower than it looks: PI 006-4 does not cover computerised-system validation, which sits in Annex 11, does not treat analytical method validation in depth, and does not repeat validation topics already covered by other PIC/S documents such as PI 007 on aseptic processes. It supplements Annex 15 rather than restating it — the topics are the areas PIC/S inspectorates identified as needing more guidance than Annex 15 gives.
What are the key requirements of PIC/S PI 006-4?
PIC/S PI 006-4 requires, among other things: Maintain a validation master plan with a defined principle, purpose, scope, format and content; Run prequalification stages before the qualification stages proper, then IQ, OQ and PQ for facilities, supporting utilities, equipment and systems; Define and justify requalification, rather than treating qualification as a one-time event; Apply quality risk management principles throughout qualification and validation.
When was PIC/S PI 006-4 last updated?
The current version of PIC/S PI 006-4 dates from October 2026. PI 006-4 enters into force 1 October 2026, superseding PI 006-3 of 25 September 2007 — a nineteen-year gap. It also renames the document: PI 006-3 was titled “Recommendations on validation master plan, installation and operational qualification, non-sterile process validation, cleaning validation”, and PI 006-4 is simply “Recommendations on Qualification and Validation”, reflecting the 2015 revision of Annex 15. PIC/S announced the revision on 30 July 2026; the working group was chaired successively by Norman Gray (MHRA) and then jointly by Kevin O’Donnell (HPRA) and Rebecca Dowd (US FDA). Separately, EMA and PIC/S have agreed a concept paper on revising Annex 15 itself (EMA/INS/GMP/163466/2026, 19 January 2026), so the underlying annex is also in motion.
This standard in practice
Recall domain is a SPEQ mapping of this standard’s topics, not an FDA classification.